Medical Lasers Market Set To Grow To Over $5bn By 2027

10 August 2018
Pharma

Visiongain has launched a new pharma report Medical Laser Systems Market Forecast 2017-2027: Analysis of Medical Lasers for Ophthalmology, Dermatology, Dental, Gynaecology, Urology and Cardiology; Forecasts for Diode Lasers, Solid-State Lasers, Gas Lasers, Dye Lasers and Major National Markets with an Assessment of Leading Companies

Several biological effects can be produced by the action of a laser beam on a biological tissue. There are four main effects caused by the transfer of energy from the laser to the tissue: thermal effect, photoablative effect, electromechanical effect and photochemical effect. The effects are affected by the absorption properties of the chromophores in human tissues.

Surgical use was the first application of lasers in medicine. For example, CO2 lasers (10,600nm) work by heat generated following absorption of photons. Tissue coagulates at 60 degrees and carbonises above 200 degrees with a sharp transition from affected to non-affected regions of the tissue due to localised absorption.

The absorption of proteins increases when shorter wavelengths are used. This leads to shallow penetration depths. Short-pulse lasers can result in energy deposition in a very shallow region, followed by explosive expansion of the generated plasma. Cell layers can be removed in precision surgery such as those in corneal reshaping. Other short wavelength lasers such as excimer lasers with fibre tips have the potential to be used for laser ablation of atherosclerotic plaques in the coronary arteries.

The lead Visiongain report analyst for this report commented; “Medical laser systems provide novel solutions for medical treatments. In the past decade, lasers in ophthalmology have had great success. The growing ageing population in developed markets and the increasing prevalence of ocular diseases has contributed to the success of this market. Recently, there has been a surge in the demand for medical lasers for use in dermatology and gynaecology. This has been driven by the improved safety of devices and the transition from using lasers in the traditional medical setting to the ease of use at home. Visiongain believes that there is great opportunity for growth within the medical laser systems market over the next ten years. However, Visiongain notes that the recent economic slowdown in BRIC markets coupled with continuing economic difficulty in European countries and the uncertainty brought about by UK’s decision to leave the EU may influence investments made over the decade.”

The Medical Lasers market is highly competitive with many different players entering the market. The report discusses selected leading companies in the market. These companies include American Medical Systems, Carl Zeiss Meditec, Coherent, Cynosure, ForTec Medical, Lumenis, Syneron Candela and Topcon.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

Read

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

Read

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

Read

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever